Cargando…

The immunomodulatory role of tumor Syndecan-1 (CD138) on ex vivo tumor microenvironmental CD4(+) T cell polarization in inflammatory and non-inflammatory breast cancer patients

Herein, we aimed to identify the immunomodulatory role of tumor Syndecan-1 (CD138) in the polarization of CD4(+) T helper (Th) subsets isolated from the tumor microenvironment of inflammatory breast cancer (IBC) and non-IBC patients. Lymphocytes and mononuclear cells isolated from the axillary tribu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saleh, Moshira Ezzat, Gadalla, Ramy, Hassan, Hebatallah, Afifi, Ahmed, Götte, Martin, El-Shinawi, Mohamed, Mohamed, Mona Mostafa, Ibrahim, Sherif Abdelaziz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6542534/ https://www.ncbi.nlm.nih.gov/pubmed/31145753 http://dx.doi.org/10.1371/journal.pone.0217550

Ejemplares similares

Induction of heparanase via IL-10 correlates with a high infiltration of CD163+ M2-type tumor-associated macrophages in inflammatory breast carcinomas
por: El-Nadi, Mennatullah, et al.
Publicado: (2020)

Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways
por: Ibrahim, Sherif Abdelaziz, et al.
Publicado: (2017)

Syndecan-1 (CD138), Carcinomas and EMT
por: Couchman, John R.
Publicado: (2021)

Prevalence of Syndecan-1 (CD138) Expression in Different Kinds of Human Tumors and Normal Tissues
por: Kind, Simon, et al.
Publicado: (2019)

Syndecan-1 (CD138) Modulates Triple-Negative Breast Cancer Stem Cell Properties via Regulation of LRP-6 and IL-6-Mediated STAT3 Signaling
por: Ibrahim, Sherif A., et al.
Publicado: (2013)

Inflammatory breast cancer: Activation of the aryl hydrocarbon receptor and its target CYP1B1 correlates closely with Wnt5a/b-β-catenin signalling, the stem cell phenotype and disease progression
por: Mohamed, Hossam T., et al.
Publicado: (2018)

The Intensity and Pattern of Syndecan-1 (CD138) Expression in Normal and Diseased Livers
por: Atique, Muhammad, et al.
Publicado: (2023)

An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situ
por: Götte, Martin, et al.
Publicado: (2007)

Syndecan-1 (sCD138) levels in chronic lymphocytic leukemia: clinical and hematological correlations
por: Sharma, Monica, et al.
Publicado: (2018)

Tumor and microenvironmental mechanisms of resistance to immunomodulatory drugs in multiple myeloma
por: Chen, Lucia Y., et al.
Publicado: (2022)

Soluble syndecan-1 (CD138): is it useful as a prognostic factor in Korean patients with multiple myeloma?
por: Lee, Je-Jung
Publicado: (2010)

Disease Stage-Specific Pathogenicity of CD138 (Syndecan 1)-Expressing T Cells in Systemic Lupus Erythematosus
por: Liu, Lunhua, et al.
Publicado: (2020)

Utility of CD138/syndecan-1 immunohistochemistry for localization of plasmacytes is tissue-dependent in B6 mice
por: Meyerholz, David K., et al.
Publicado: (2022)

Revisiting the Syndecans: Master Signaling Regulators with Prognostic and Targetable Therapeutic Values in Breast Carcinoma
por: Motta, Juliana Maria, et al.
Publicado: (2023)

Relationship between circulating syndecan-1 levels (CD138s) and serum free light chains in monoclonal gammopathies
por: Cigliana, Giovanni, et al.
Publicado: (2015)

CD10 and CD138 can be expressed in giant cell tumor of bone: An immunohistochemical study
por: Al-Abbadi, Mousa A., et al.
Publicado: (2016)

Role of adipose tissue-derived cytokines in the progression of inflammatory breast cancer in patients with obesity
por: Ibrahim, Aya Saber, et al.
Publicado: (2022)

Syndecan-1 Promotes Angiogenesis in Triple-Negative Breast Cancer through the Prognostically Relevant Tissue Factor Pathway and Additional Angiogenic Routes
por: Nassar, Eyyad, et al.
Publicado: (2021)

Syndecan-1 (CD138) deficiency increases Staphylococcus aureus infection but has no effect on pathology in a mouse model of peritoneal dialysis
por: Kowalewska, Paulina M., et al.
Publicado: (2016)

Heparanase-induced shedding of syndecan-1/CD138 in myeloma and endothelial cells activates VEGFR2 and an invasive phenotype: prevention by novel synstatins
por: Jung, O, et al.
Publicado: (2016)

Raised Serum Levels of Syndecan-1 (CD138), in a Case of Acute Idiopathic Systemic Capillary Leak Syndrome (SCLS) (Clarkson’s Disease)
por: Bøe, Ole Wilhelm, et al.
Publicado: (2018)

Inflammatory Breast Carcinoma: Elevated microRNA miR-181b-5p and Reduced miR-200b-3p, miR-200c-3p, and miR-203a-3p Expression as Potential Biomarkers with Diagnostic Value
por: Fahim, Sarah Atef, et al.
Publicado: (2020)

Inflammatory Biomarkers Profile as Microenvironmental Expression in Keratoconus
por: Ionescu, Catalina, et al.
Publicado: (2016)

Immunomodulatory effects of soluble CD5 on experimental tumor models
por: Simões, Inês T., et al.
Publicado: (2017)

Small extracellular vesicle-encapsulated miR-181b-5p, miR-222-3p and let-7a-5p: Next generation plasma biopsy-based diagnostic biomarkers for inflammatory breast cancer
por: Ahmed, Sarah Hamdy, et al.
Publicado: (2021)

Loss of Heterozygosity in the Circulating Tumor DNA and CD138+ Bone Marrow Cells in Multiple Myeloma
por: Soloveva, Maiia, et al.
Publicado: (2023)

Infrared Microspectroscopy and Imaging Analysis of Inflammatory and Non-Inflammatory Breast Cancer Cells and Their GAG Secretome
por: Mohamed, Hossam Taha, et al.
Publicado: (2020)

A Comparison of Ki67, Syndecan-1 (CD138), and Molecular RANK, RANKL, and OPG Triad Expression in Odontogenic Keratocyts, Unicystic Ameloblastoma, and Dentigerous Cysts
por: Brito-Mendoza, Luisana, et al.
Publicado: (2018)

Differential Impact of Membrane-Bound and Soluble Forms of the Prognostic Marker Syndecan-1 on the Invasiveness, Migration, Apoptosis, and Proliferation of Cervical Cancer Cells
por: Hilgers, Katharina, et al.
Publicado: (2022)

Syndecan-1 as a Regulator of Chemokine Function
por: Götte, Martin, et al.
Publicado: (2003)

Phenotypic, Genomic and Functional Characterization Reveals No Differences between CD138(++) and CD138(low) Subpopulations in Multiple Myeloma Cell Lines
por: Paíno, Teresa, et al.
Publicado: (2014)

Noncoding RNAs as sensors of tumor microenvironmental stress
por: Lv, Yue, et al.
Publicado: (2022)

Microenvironmental Factors that Shape Bacterial Metabolites in Inflammatory Bowel Disease
por: Lopez, Lacey R., et al.
Publicado: (2022)

Comparison of the IHC Markers CD138 and CD43 in Oral Leukoplakia: An Original Research
por: Akkaloori, Anitha, et al.
Publicado: (2023)

Syndecans in tumor cell adhesion and signaling
por: Beauvais, DeannaLee M, et al.
Publicado: (2004)

A syndecan-based tumor stopper
por: Maxmen, Amy
Publicado: (2009)

Syndecan-4 in Tumor Cell Motility
por: Keller-Pinter, Aniko, et al.
Publicado: (2021)

Syndecan receptors: pericellular regulators in development and inflammatory disease
por: Gopal, Sandeep, et al.
Publicado: (2021)

Role and mechanism of CD90(+) fibroblasts in inflammatory diseases and malignant tumors
por: Zeng, Feng, et al.
Publicado: (2023)

Syndecan-1 deficiency promotes tumor growth in a murine model of colitis-induced colon carcinoma
por: Binder Gallimidi, Adi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_a2fv459cu9q4sobvllq2018lub